BioVAT-HF Phase 1/2 Reveals First Evidence for Effective
Featured Late Breaking Clinical Science presentation at American Heart Association Scientific Sessions in PhiladelphiaSafe Maximal Dose Confirmed with...
Source: globenewswire.com
Pluripotent Stem News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pluripotent Stem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pluripotent Stem Today - Breaking & Trending Today
Clinical Trials Using iPSCs for Heart Diseases, Stroke, and Cancer Treatment Propel Induced Pluripotent Stem Cell Market Growth
Induced Pluripotent Stem Cell ((iPSC) Market Induced Pluripotent Stem Cell ((iPSC) Market Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Induced Pluripotent Stem Cell ((iPSC) estimated at US$1.8 Billion in the year 2022, is projected to reach a revised size of US$3.1 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030.
Source: yahoo.com
QNRF holds ROS seminar on research in health and sustainability
QNRF holds ROS seminar on research in health and sustainability
Source: gulf-times.com
CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology - CytoMed Therapeutics (NASDAQ:GDTC)
SINGAPORE / ACCESSWIRE / October 24, 2023 / CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company focused on utilizing its licensed proprietary
Source: benzinga.com
CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing ...
CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing ...
Source: pr-inside.com